Ariad Pharmaceuticals Inc (ARIA) insider trading

Every open-market stock purchase and sale by Ariad Pharmaceuticals Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

No open-market insider trades in the last 12 months.
Last insider buy: Paris Panayiotopoulos (CEO), $200K, 10 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $23.94 on Oct 22, 2026.

Recent ARIA insider trades

No open-market trades in the last 12 months.

Get free alerts when an insider at Ariad Pharmaceuticals Inc files a new trade →